A pilot study evaluating the fidelity of ChatGPT in client simulations
Journal of Counselor Preparation and Supervision · 2025-08 · 19 (3) · 1-16
DOI: 10.70013/d2a58d79 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Counselor Preparation and Supervision, 2025-08. Verfasst von Eric Beeson und 4 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Generative AI (genAI) is expanding in counselor education. This pilot study evaluated ChatGPT 4o's voice mode for simulating client scenarios during 53-minute mock-intake sessions with master’s-level counseling students. Analyzing eight domains (authenticity, consistency, emotional expression, empathy, cultural dynamics, self-awareness, goal setting, and role play confusion), ChatGPT’s responses showed good to excellent fidelity when compared to a typical client. Limitations such as formulaic and idealized responses raised authenticity concerns. ChatGPT offers a scalable, cost-effective tool for pre-practicum training, with potential to enhance skill development across the curriculum. Educators are encouraged to integrate genAI thoughtfully, prioritizing ethical considerations and iterative prompt refinement.
Zitieren
APA
Beeson, E., Zhai, Y., Fulmer, R., Burck, A., & Maurya, R. (2025). A pilot study evaluating the fidelity of ChatGPT in client simulations. Journal of Counselor Preparation and Supervision, 19(3), 1-16. https://doi.org/10.70013/d2a58d79
Vancouver
Beeson E, Zhai Y, Fulmer R, Burck A, Maurya R. A pilot study evaluating the fidelity of ChatGPT in client simulations. Journal of Counselor Preparation and Supervision. 2025;19(3):1-16. doi:10.70013/d2a58d79
BibTeX
@article{Beeson2025,
author = {Beeson, Eric and Zhai, Yusen and Fulmer, Russell and Burck, Andrew and Maurya, Rakesh},
title = {A pilot study evaluating the fidelity of ChatGPT in client simulations},
journal = {Journal of Counselor Preparation and Supervision},
year = {2025},
volume = {19},
number = {3},
pages = {1--16},
doi = {10.70013/d2a58d79}
}
EUVIMED